Companies / IN8bio, Inc.
IN8bio, Inc.
Nasdaq: INABCIK 1740279NEW YORK, NY
Financials
Ownership
9.9M shares outstanding · as of Aug 3, 2026
Ownership
| 10%+ / strategic | 19.08% | 1,880,912 |
| Institutions | 14.42% | 1,421,634 |
| Public float | 66.50% | 6,555,837 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 4
View all →| Insider | % of shares | Shares |
|---|---|---|
Ho William Tai-WeiCEOCEO · Director · 10% owner | — | — |
Lamb LawrenceFormerEVP and CSO | — | — |
McCall PatrickCHIEF FINANCIAL OFFICER | — | — |
Rochlin KatePresident and COO | — | — |
Institutional holders 22
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.23M | 9.71% | |
| $2.05M | 9.28% | |
| $1.70M | 7.35% | |
| $593.0K | 2.57% | |
| $385.9K | 1.67% | |
| $127.6K | 0.87% | |
| $85.1K | 0.37% | |
| $66.3K | 0.29% | |
| $66.0K | 0.29% | |
| $42.8K | 0.19% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Ho William Tai-Wei CEO | Grant | Employee Stock Option (right to buy) | — | +206K | 206,000 2.09% of shares | low |
| Feb 4, 2026 | Lamb Lawrence Executive | Grant | Employee Stock Option (right to buy) | — | +72K | 72,000 0.73% of shares | low |
| Feb 4, 2026 | Rochlin Kate Executive | Grant | Employee Stock Option (right to buy) | — | +80K | 80,000 0.81% of shares | low |
| Feb 4, 2026 | McCall Patrick Executive | Grant | Employee Stock Option (right to buy) | — | +75K | 75,000 0.76% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Lytton Laurence W | Passive13G | — |
| Alyeska Investment Group, L.P. | Passive13G | — |
| Franklin Resources, Inc. | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| INAB | Common Stock | 45674E208 |